LOVFF OTC
Cannara Biotech Inc.
1W: -2.0%
1M: +2.1%
3M: +25.4%
YTD: +13.8%
1Y: +15.6%
3Y: +113.1%
5Y: +2.8%
$1.48
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$20M
+87.3% ▲
Capital Expenditures
$6M
+14.9% ▲
5Y CAGR: -6.3%
Free Cash Flow
$14M
+324.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$8M
+229.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | $2M | $7M | $6M | $13M |
| Depreciation & Amort. | $3M | $4M | $5M | $6M | $7M |
| Stock-Based Comp. | $332K | $349K | $2M | $2M | $1M |
| Change in Working Capital | -$4M | -$11M | -$6M | -$2M | -$8M |
| Other Non-Cash Items | -$169K | -$659K | -$2M | $368K | $7M |
| Operating Cash Flow | -$2M | -$6M | $6M | $11M | $20M |
| — Investing Activities — | |||||
| Capital Expenditures | -$31M | -$15M | -$10M | -$7M | -$6M |
| Acquisitions (Net) | $217K | $63K | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $27K | $59K | $402K | $2M | $409K |
| Investing Cash Flow | -$31M | -$15M | -$9M | -$5M | -$6M |
| — Financing Activities — | |||||
| Net Debt Issuance | $10M | $28M | -$2M | $1M | -$3M |
| Stock Repurchased | $0 | $0 | -$374K | -$277K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$1M | -$2M | -$1M | -$4M | -$4M |
| Financing Cash Flow | $33M | $25M | -$4M | -$3M | -$6M |
| Net Change in Cash | $388K | $4M | -$8M | $2M | $8M |
| Cash End of Period | $8M | $12M | $4M | $7M | $14M |
| Free Cash Flow | -$33M | -$22M | -$4M | $3M | $14M |